Objectives: To determine the IgG subclass levels of patients admitted to Harare Central Hospital paediatric wards with pneumonia. Design: A cross sectional study. 
Introduction
More recent studies" ' have show n that the concentrations of total IgGl and IgG3. in various mucosal fluids, are increased in HIV-infected individuals while those of IgG2 and IgG4 tire decreased. Furthermore, the concentrations of specific IgGl and IgGo antibodies to HIV virus arc correspondingly increased in the same HIV-infected subjects while specific IgG2 and lgG4 antibodies were reduced. It is now established that IgG2typc antibodies arc the most effective against encapsulated bacteria such as Streptococcus pneumoniae, particularly in young children." It would appear that children with low IgG2 levels would have correspondingly low levels of IgG2-tvpc antibodies Bacterial pneumonia is the commonest cause of morbidity' and mortality in Zimbabwe.1 'flic children most at risk are those infected with 1 ii\ 3 • We reported, in a recent study2 that the great majority of children admitted to hospital with pneumonia have hypergammaglobulinaemia in immunoglobulins A (IgA). G (IgG) and V I (IgM). IgG was the most raised immunoglobulin class with concentrations of up to 10 times that of normal age-matched reference ranges. The report was in agreement with other studies done previously."'' and therefore a deficient humoral immune response to encapsulated bacteria. Such a deficient immune response would be further compromised by HIV infection.
The main objective of this study was to investigate the relationship between levels of IgG subclasses and the occurrence of pneumonia in children aged one month to six years with or without evidence of HIV infection.
Material and Methods

Patients.
The study population consisted of children, between the ages of one month and six years, admitted to hospital with pneumonia. The diagnosis of pneumonia was based on the World Health Organisation (WHO) clinical definition consisting of cough associated with difficulty in breathing.9 Fifty six children with pneumonia, selected consecutively over a period of five months, were included in the study. Children with a history of asthma were excluded from the study. Parental consent was sort for all children used in the study.
Collection of Blood Samples.
Between two and five mis of venous blood was taken from each child into a plain tube for clotting. Serum was separated, aliquoted and stored at -20°C.
IgG Subclass Determinations.
IgGl, IgG2, IgG3 and IgG4 were measured by radial immunodiffusion (RID) assay using kits purchased from Binding Site (Birmingham, United Kingdom). All assays were perform ed according to the m anufacturers' instructions. Briefly, equal volumes of serum from the patients were added to separate wells of the RID plates and the plates incubated at 37°C for 16 hours. Diameters of precipitin rings formed were measured with the aid of a magnifying glass and the concentrations calculated against the standards. Levels of these immunoglobulin subclasses were expressed in milligrams per millilitre (mg/ml). Normal reference ranges (+2SD) were taken from the publication entitled 'Handbook of Clinical Immunology Service'1 " used in routine Immunology Labs in Zimbabwe's Public Health Laboratories. HIV Screening.
Serum from each patient was tested for HIV using three different enzyme-linked immunosorbent assay (ELISA) kits. All assays were performed in accordance with the manufacturers' instructions. Two independent HIVELISA antibody kits (Genelavia, Sanofi Diagnostics, Pasteur, France; Human, Wiesbaden, Germany) were used to determine the presence of antibodies to HIV 1/2. Briefly, serum from each patient sample was incubated in HIV 1/2 antigen-coated wells. After washing, an antibody-enzyme conjugate to human IgG was added and a second incubation done followed by further washing. A final incubation step with the enzyme substrate was done and colour development read at 405nm on the Coda Automated EIA Analyser (Biorad Laboratories, Hertfordshire, UK).
Because of persistence of maternal antibodies in children up to the age of about 18 months, a third HIV screening test, an HIV ELISA antigen test (Murex Chatillon, France), which detects the presence of the p24 antigen shed from the HIV 1 virus,11 was used. Briefly, the method used was similar to the one above except that the ELISA plate wells were coated with antibody to the HIV virus
Results
Of the 56 patients studied, 40 (71 %) had antibodies to HIV while 16 (29%) had no detectable antibodies to HIV. Of the 40 with antibodies to HIV, 22 had detectable HIV p24 antigen in their sera. HIV p24 antigen was not detected in any of the 16 HIV antibody negative patients. Although there was substantial variation between individuals in the levels of IgG subclasses, IgGl subclass concentrations were markedly higher in HIV antibody positive (HIV Ab+) than in HIV antibody negative (HIV A b ) patients (see Table I ). Even when the medians for the IgG subclasses were compared between the HIV Ab+ and HIV A b ', as Table II shows, IgGl and IgG3 median levels are significantly higher (p<0.001 for each of the 2 subclasses) in HIV Ab+ patients. We found no significant differences in the levels of IgG2 and IgG4 between HIV Ab+ and HIV Ab' patients. IgG subclass levels were also compared between HIV p24 antigen positive (HIVAg+) patients and those without detectable p24 antigen in their sera (HIVAg), in the same population group. Of the 56 patients, 22 (39%) were HIV Ag+ while 34 (61%) were HIVAg'. No significant differences were observed in the mean concentrations of each subclass between the two groups, as Table 111 shows. Similarly, no significant differences were observed when the medians of the IgG subclasses were compared between HIV Ag+ and HIV Ag'patients (Table IV) . The results were then subjected to multiple regression analysis with respect to age, gender, HIV Ab status and HIV Ag status. The coefficients of variation calculated across the IgG subclasses (see Table V ) clearly showed that abnormally high levels of IgGl and IgG3 in the patients studied were significantly associated with the presence of antibodies to HIV (p-values of <0.001 and 0.010, respectively). Age, gender and the presence of HIV p24 antigen had no significant influence on the levels of the IgG subclasses in this population. 
Discussion
The present study has established the pattern of distribution of IgG subclasses in children admitted to Harare Hospital with pneumonia, with or without evidence of HIV coinfection. Abnormally high levels IgGl and IgG3 were significantly associated with the presence of HIV antibodies.
The association between the levels of IgG2 and the presence of HIV antibody was not significant. Similarly, we did not find any association between the levels of IgG4 and the presence of HIV antibodies. To our knowledge, this is the first study of its kind to be conducted in Zimbabwe and the results are in agreement with other recently published reports.6'7 Factors such as age, gender and the presence or absence of HIV-p24 antigen did not appear to influence the pattern of IgG subclass levels in our study population. The apparent lack of association between levels of IgG subclasses and presence or absence of HIVp-24 antigen may be due to lower sensitivities of the p-24 assays12 compared to those of established HIV antibody assays.
HIV antibody tests are the most widely used in adult subjects to screen for HIV. Such methods are not concl usive in children under the age of 18 months, because of persistence of m aternally acquired an tib o d ies.13' 14 Furthermore, HIV-p24 antigen tests have their limitations too as high sensitivities of about 80% appear to be achievable only in infants of up to two months -beyond that age the sensitivities tend to progressively diminish although specificity remains high.12 Our results clearly suggest that abnormally raised IgG 1 and IgG3 in children presenting with pneumonia appear to be strongly suggestive of concurrent HIV infection. Used as a diagnostic tool, IgGl profiles would be relatively cheaper, particularly in the developing world, compared to other conventional techniques.
A recent study supports the same view.15 Although the presence of abnormally high levels of IgGl and IgG3 will not conclusively prove that a child is infected with HIV, but taken together with the mother's HIV antibody status could strengthen the clinician's suspicion that there might be underlying HIV infection. Appropriate clinical management regimes could then be applied to those children at risk found to have high IgGl and IgG3 levels.
A future study could look at profiles of neutralising antibody isotypes in children born to HIV seropositive mothers in a longitudinal study. Special focus would be given to those children who remain or become seronegative with time.
